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Abstract: 18 
Despite ongoing research in a number of species, the efficiency of embryo production by 19 
nuclear transfer remains low. Incomplete epigenetic reprogramming of the nucleus introduced 20 
in the recipient oocyte is one factor proposed to limit the success of this technique. Nonetheless, 21 
knowledge of reprogramming factors has increased -thanks to comparative studies on 22 
reprogramming of the paternal genome brought by sperm upon fertilization- and will be 23 
reviewed here. Another valuable model of reprogramming  is the one obtained in the absence 24 
of sperm fertilization through artificial activation - the parthenote- and will also be introduced. 25 
Altogether the objective of this review is to have a better understanding on the mechanisms 26 
responsible for the resistance to reprogramming; not only because it could improve embryonic 27 
development but also as it could benefit therapeutic reprogramming research.  28 
Keywords: Oocyte ; Nuclear transfer ; Embryonic genome activation ; Histones post-29 
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Introduction to Nuclear Reprogramming  32 
The cells of an adult mammal show a striking variation in structure and function, conferred by 33 
the differential expression of tightly regulated and specific gene networks. With few exceptions, 34 
individual cell types have been shown to retain the entire genetic content of the totipotent 35 
embryo. Yet, specific gene expression patterns associated with differentiated cell states are 36 
highly stable and conserved after somatic cell division [1]. The process of restricting expression 37 
to lineage-appropriate subsets of genes is ongoing throughout development and is now 38 
understood to reflect an accumulation of “epigenetic” changes at specific gene loci [2] and [3]. 39 
The term epigenetics, coined by Conrad Waddington in the 1940s, is now used to refer to “the 40 
study of changes in gene function that are mitotically and/or meiotically heritable and that do 41 
not entail changes in DNA sequence” [4] and [5]. These changes include the large scale 42 
positioning of chromosomes and genes within the nucleus as well as local modifications to 43 
DNA and chromatin [6] and [7]. Epigenetic changes affect the accessibility of DNA to the 44 
transcription machinery, hence, gene expression [6] and [7]. Local modifications include 45 
histone posttranslational modifications (PTMs such as methylation, acetylation, 46 
phosphorylation, and so forth), DNA methylation, and remodeling of the chromatin [4] and [8]. 47 
Moreover, all these local modifications may specifically recruit factors, as in recruitment of 48 
bromodomain proteins to acetylated histones and of chromobox family proteins to methylated 49 
histones [9]. 50 
Each differentiated cell type has a specific profile of epigenetic modifications at key loci, 51 
resulting in expression of only type-appropriate genes. Deviations from this profile in vivo are 52 
frequently associated with disease [10]. It is also increasingly recognized that deviations from 53 
normally observed epigenetic patterning can contribute to the altered cell behavior found by 54 
cancer cells [11]. On the other hand, alteration of these epigenetic modifications with the aim 55 
of conferring a more developmentally plastic cell state is referred as nuclear reprogramming 56 
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and is attempted experimentally via a number of different techniques [12] and [13]. The first 57 
amphibian and mammalian cloned animals were achieved by inserting a donor nucleus into an 58 
enucleated recipient oocyte [14]. In this approach (cloning by nuclear transfer [NT]), the oocyte 59 
has to reprogram the injected nucleus, trying to mimic reprogramming of maternal and paternal 60 
DNA during natural fertilization (Fig. 1) [15]. Mammalian nuclei have also been reprogrammed 61 
by transfer to the germinal vesicle of Xenopus oocytes [13] and [16] or by the fusion of donor 62 
cells with an “embryonic dominant” cell type [12]. These techniques use the natural 63 
reprogramming abilities of oocytes, embryos, and embryonic cells, without requiring 64 
knowledge of the precise factors required for reprogramming. However, as knowledge of 65 
reprogramming factors has increased, alternative techniques involving exposure of cells to 66 
specific combinations of transcription factors have grown in popularity. Nowadays, somatic 67 
cells can be virally transfected, at least in mouse, with no more than four key transcription 68 
factors (Oct4, Sox2, Klf4, and Myc) to induce pluripotency (Fig. 1) [17]. The availability of 69 
induced pluripotent stem cells (iPS cells) from different species is also increasing rapidly [18], 70 
although the underlying molecular mechanisms remain to be investigated. Specific 71 
combinations of transcription factors have also been used to switch directly from one cell type 72 
to another, a process known as transdifferentiation [19]. 73 
The goals of this experimental nuclear reprogramming are twofold. First, to elucidate the roles 74 
of different epigenetic marks (and associated protein complexes) in nuclear reorganization at 75 
fertilization and during development and, second, to develop applications that benefit to human 76 
health. Such applications include the reprogramming of readily accessible cell types such as 77 
dermal fibroblasts to produce cell lines (iPS cells) to be used for drug screening or study of 78 
disease pathways [20] and [21]. These iPS cell lines could be used to select the most effective 79 
treatment for the individual patient or for the production of cells and organs for autologous 80 
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transplants without the ethical or immunological problems associated with allogeneic 81 
transplantation [20] and [21]. 82 
As a research tool, nuclear reprogramming continues to yield insights into the mechanisms and 83 
complexes involved in differential control of gene expression [13]. Despite this, and successful 84 
cloning experiments in a wide range of species, the efficiency of all techniques, as measured by 85 
proportion of nuclei leading to developmentally plastic cells or healthy adult animals, remains 86 
very low. Considering the possible therapeutic benefits of successful nuclear reprogramming, 87 
there is a great deal of interest in understanding the mechanisms responsible for this resistance 88 
to reprogramming. 89 
 90 
Reprogramming at Fertilization  91 
 92 
In mammalian species, the formation of the embryo begins with the fusion of two highly 93 
specialized haploid cells (sperm and oocyte) which gives place to a genetically new diploid 94 
organism: the zygote (or 1-cell stage embryo) with two haploid “pro” nuclei, the paternal and 95 
the maternal one (Fig. 1). The “early mammalian” or “preimplantation” embryo development 96 
compresses the time from fertilization until the implantation of the embryo in the mother's 97 
uterus. During this period of development, epigenetic reprogramming of the genome inherited 98 
from the gametes is crucial [22] and [23]. Indeed, during the formation of gametes, both oocyte 99 
and sperm cells are subjected to epigenetic changes that permit the expression of specific genes 100 
required for germ cell development. As gamete maturation is near to completion, a 101 
reorganization of the genome occurs. Paternal genome becomes highly methylated and compact 102 
as histones are replaced by protamines [24] and [25]. On the other hand, the oocyte undergoes 103 
a chromatin restructuring from a nonsurrounded nucleolus (open chromatin with few defined 104 
chromatin surrounding the nucleolus and transcriptionally active) to a surrounded nucleolus 105 
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conformation (highly condensed chromatin with clear presence of chromatin around the 106 
nucleolus and transcriptionally silent) (Fig. 2) [26] and [27]. 107 
From fertilization, both the incoming paternal DNA complement and that of the oocyte itself 108 
are reprogrammed in a number of steps, resetting chromatin to the embryonic form capable of 109 
undergoing further changes required during development [28] and [29]. The defined epigenetic 110 
status of the previous gametes' genome must now turn into a whole new epigenome proper of 111 
an early embryo with totipotent capacity [23], [30] and [31]. To do so, the paternal and maternal 112 
genome undergo global demethylation, and although many studies have led to contrasted results 113 
regarding the dynamics and the extend of this demethylation [32], it appears that the 114 
demethylation process continues after the first cell cycle in the preimplantation embryo up to 115 
the blastocyst stage in many mammals [33], [34], [35], [36] and [37]. At this point, the first cell 116 
lineage determination takes place (the formation of the inner cell mass (ICM) and of the 117 
trophectoderm (TE)) and new methylation patterns emerge together with cell differentiation 118 
and specialization until the whole organism is formed [35], [38] and [39]. 119 
In addition to this DNA demethylation occurring after fertilization, it has been shown in mouse 120 
that many of the histones replacing the protamines on the paternal genome are already 121 
acetylated such as lysines 8 and 12 of histone H4 [40]. Moreover, for a correct development, 122 
the paternal pronuclei has to be hyperacetylated with the further acetylation of lysines 5 and 16 123 
of H4 and lysines 9, 14, 18, and 27 of histone H3 [31], [41] and [42]. On the other hand, some 124 
histone PTMs such as trimethylation of lysine 20 on histone H4 and trimethylation of lysine 9 125 
on histone H3 (H3K9me3, Fig. 2) are inherited exclusively from the maternal pronucleus, 126 
creating an asymmetry between the two parental genomes in the embryo (it would not be 127 
possible to include in this work all known histone PTMs, their fluctuation and their roles; for a 128 
complete review of known histone PTMs see [30]). These asymmetries persist for varying 129 
lengths of time in the developing embryo. For an example, lysine 4 methylation on histone H3 130 
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is evenly distributed throughout DNA by the two-cell stage [42], whereas H3K9me3 remains 131 
asymmetrically distributed until the four-cell stage [30]. Other modifications are found to differ 132 
from the ICM and TE cells, such as H4/H2AS1P which is much frequent in the nucleosomes 133 
of TE than ICM cells [43] or the general methylation of H3K27 which is found only in the ICM, 134 
whereas in the TE it is only present in the inactivated X chromosome [44]. 135 
The function of this asymmetry just after fertilization has not yet been fully understood, 136 
although it is thought to be required for a proper development. Indeed, embryos are 137 
transcriptionally silent until the end of the one-cell stage, when a small number of embryonic 138 
genes are transcribed from the paternal genome [45] and [46]. This asymmetrical minor 139 
activation is followed by the major embryonic genome activation (EGA) later on, associated 140 
with a much more frequent rate of production of transcripts and the number of genes transcribed 141 
[46] and [47]. The reprogramming of histone modifications has been proposed to be significant 142 
for triggering transcription and EGA, correlating the accumulation of transcriptionally 143 
permissive marks on the paternal genome and minor activation and between more widespread 144 
reprogramming and EGA [48], [49] and [50]. Among the differences observed in 145 
preimplantation embryo between mammalian species, the timing of embryo genome activation 146 
is a major one. In mouse embryos, EGA occurs at two-cell stage, whereas in bovine and rabbit 147 
embryos it occurs at the eight-cell stage [51] and [52]. Remarkably though, it is believed that 148 
the fourth-fifth cell cycle in the bovine embryos is critical for chromatin remodeling and 149 
embryos that are unable to modify their chromatin structure for gene activation arrest at this 150 
stage. For example, distribution of H3K27me3 has been studied semiquantitatively in bovine 151 
embryos, where levels were found to decrease from oocytes to their minimum at eight-cell 152 
stage, corresponding with EGA [53] and [54]. The decline in H3K27me3 is independent of cell 153 
division, indicating an active removal mechanism, where histone demethylase KDM6B has 154 
been implicated as the enzyme catalyzing the removal [55]. Similarly, it appears that sheep 155 
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oocytes and embryos have a specific Dnmt1 transcript involved in DNA methylation 156 
maintenance whose levels decrease when the embryonic genome becomes active at the 8/16-157 
cell stage. Interestingly, reducing Dnmt1(12b) by RNA interference prevents embryo 158 
compaction at the morula stage, showing the importance of DNA methylation for embryonic 159 
preimplantation development [56]. 160 
Therefore, it seems that although the dynamics of some epigenetic marks are not conserved 161 
between all mammalian species, they are always closely related with the formation of an “open” 162 
chromatin state allowing gene expression regulation during preimplantation development. 163 
 164 
Reprogramming after cloning by Nuclear Transfer 165 
Cloned embryos are the result of the enucleation of an oocyte and transfer of the diploid nucleus 166 
from another cell (Fig. 1). After such NT procedure, donor cell nuclei often get an incomplete 167 
reprogramming which is thought to lead to abnormal development in clones [15]. In particular, 168 
the donor chromatin needs to undergo epigenetic changes and modifications to get an 169 
embryonic-like chromatin structure as seen in sheep, mouse, bovine, and rabbit NT embryos 170 
[57], [58], [59] and [60]. The timing and manner to achieve this conformation will depend on 171 
the type of cell used as donor for NT. Embryonic stem (ES) cells proliferate fast and appear to 172 
have a more open chromatin conformation than cumulus cells, which may have a more 173 
compacted genomic structure. This property seems to make the chromatin of ES cells more 174 
accessible to the cytoplasm of the recipient oocyte and to efficient reprogramming [61]. 175 
Similarly, we observed that NT of murine iPS cells results in higher rates of blastocysts and 176 
live-born cloned mice than embryonic fibroblasts (46% blastocysts and 1.3% liveborn for iPS 177 
cells vs. 3.5% and 0% for fibroblasts, respectively) [62]. Altogether, it seems that chromatin of 178 
the donor cells often remains too compact. 179 
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Trimethylation of lysine 9 of histone H3 has been proposed to limit the success of nuclear 180 
reprogramming. H3K9me3 is indeed associated with the repression of transcription [63], and 181 
its localization has been shown to be strongly correlated with constitutive heterochromatin, 182 
where it recruits heterochromatin protein 1 (HP1β also called chromobox protein homolog 1) 183 
[64]. H3K9me3 distribution has also been revealed to significantly expand during the 184 
differentiation of human ES cells into fibroblasts, a process which involves spreading of 185 
heterochromatin [65]. Consistent with these observations, H3K9me3 has been shown to persist 186 
after bovine and mouse NT experiments (Fig. 2) [58], [66] and [67], and H3K9me3 levels in 187 
lymphocytes have been correlated with decreased potential for nuclear reprogramming [68]. 188 
A number of approaches have targeted H3K9me3 to improve nuclear reprogramming. In cell 189 
fusion experiments by Antony et al. [69], the transient induction of histone lysine demethylase 190 
KDM4D (also known as JMJD2B) in ES cells increased the proportion of cell reprogramming 191 
by 30% despite the rapid restoration of H3K9me3 levels thereafter. Similarly, the transient 192 
expression of KDM4D caused a twofold increase in the efficiency of reprogramming somatic 193 
cells into iPSCs [70]. Recently, it was shown that removal of H3K9me3 by overexpression of 194 
KDM4D can restore transcriptional reprogramming in mouse-cloned embryos [71]. Such 195 
transient overexpression of KDM4D in cloned embryos has also been proven to efficiently 196 
improve reprogramming both in mouse and human cloning experiments, giving much higher 197 
rates of blastocysts [71] and [72]. 198 
Histone acetylation is also very important for appropriate development in preimplantation 199 
embryos. Studies regarding histone acetylation patterns in rabbit embryos [73] and bovine 200 
embryos [74], produced either by in vitro fertilization or somatic cell NT, have shown 201 
significant differences. In vitro fertilized embryos always presented higher histone acetylation 202 
compared with their counterpart cloned embryos, underlying once again the compactness of 203 
chromatin after NT. 204 
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The use of histone deacetylase inhibitors (HDACi), as scriptaid (SA) or trichostatin A (TSA), 205 
to increase of acetylated histones and helping the chromatin opening in cloned embryos has 206 
been reported. The first successful group obtaining full-term developed embryos after NT from 207 
somatic cells was the group led by Kishigami et al. [75], although at almost the same time 208 
another study was reported demonstrating that TSA could improve clone development [76]. An 209 
increase of the blastocyst yield and improvement of embryo quality after TSA treatment has 210 
been obtained with various donor cells: fibroblasts, neural stem cells, spleen cells, and cumulus 211 
cells [77]. It has also been reported that this drug can help with gene expression regulation. For 212 
example, whereas cloned embryos reported a failure in the expression of Oct4—an important 213 
factor for pluripotency maintenance—TSA treatment favored Oct4 expression in the correct 214 
number of cells at the blastocyst stage [78] and [79]. 215 
Thereafter, SA was reported to be a novel HDACi with less toxicity than TSA because it had a 216 
high efficiency, not lethal even at high concentrations [80]. Moreover, SA treatment could 217 
support full-term development of inbred cloned embryos. In fact, it appears that inhibition of 218 
HDAC is an important factor of reprogramming [81]. Hence, the use of HDACi has resulted in 219 
significant improvements in cloning efficiency of many species including human [82]. 220 
Moreover, HDACi also favors global chromatin reprogramming and thereby gene expression 221 
in several species such as mouse or pig, by acting not only on acetylation of histones but also 222 
on H3K9me3 [83] or even DNA methylation [84] and [85]. HDACi improve genome-wide gene 223 
expression regulation bringing total gene expression profile of clones to resemble that of 224 
fertilized pups [86]. We also found that addition of HDACi during the first cell cycle in cloned 225 
mouse embryos could improve nuclear remodeling of pericentromeric heterochromatin that 226 
reorganized around nucleolar precursors such as in fertilized embryos [61]. Remarkably, the 227 
use of HDACi was also correlated with increased number of ICM cells and correct further 228 
development to term [61]. 229 
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Research on somatic cell NT embryos has been very useful in portraying that these epigenetic 230 
modifications not only have the ability to alter the expression of genes but also strongly 231 
demonstrate how their misregulation can disturb preimplantation embryonic development. 232 
Developmental inefficiency of cloned embryos and aberrant chromatin state seem to be tightly 233 
linked. The use of HDACi and of histone demethylases transient expression can however 234 
promote the formation of an “open” chromatin structure after NT, improving the reorganization 235 
of early embryo nucleus and thereby reprogramming. 236 
 237 
Reprogramming in Parthenotes 238 
Research in early mammalian development is carried out mostly on fertilized embryos. 239 
However, there is another way to study embryo development. Parthenogenetic activation is 240 
another valuable model to produce embryos in the absence of sperm fertilization through the 241 
artificial activation of a metaphase II oocyte (Fig. 1) [87]. In some species (such as various 242 
fishes, ants, snakes, or amphibians) parthenogenesis is a common method of asexual 243 
reproduction in which an unfertilized oocyte is able to develop into a whole new individual. 244 
Nonetheless, in mammals, parthenogenesis does not occur naturally, and if it does, it is only a 245 
consequence of erroneous oocyte maturation and embryos never develop to term [87]. In 246 
mouse, developmental arrest of parthenotes occurs before Day 10 of gestation but this time 247 
varies among species [88]. 248 
In normal conditions, ovulated oocytes advance from metaphase I to metaphase II and they 249 
remain arrested at this stage until they are fertilized by sperm. For the first cell division to occur, 250 
a series of events triggered by the entrance of a spermatozoon, known as oocyte activation, 251 
must take place. Broadly, the main trigger factor is the phospholipase-Ç brought by the sperm 252 
into the oocyte's cytosol [89]. A number of signaling pathways are then activated, which result 253 
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in a calcium release inside the oocyte. This calcium increase is translated in the activation of 254 
Ca2+/calmodulin-dependent protein kinase II which in turn, will inactivate the “cycle blocking” 255 
proteins maturation promoting factor and cytostatic factor. The inhibition of these last two, 256 
releases the oocyte from its arrest, and activation can be confirmed by the exocytosis of cortical 257 
granules, resumption of meiosis, extrusion of the second polar body, and the formation of 258 
pronuclei. Without sperm, it is necessary to artificially induce oocyte activation if 259 
parthenogenetic embryos are to be obtained in the laboratory. There are different protocols 260 
capable of overcoming the arrested state of a metaphase II oocyte which may include 261 
temperature alterations, electrical pulses, and changes in osmolarity [87]. Contemporary 262 
protocols are mostly based on calcium mobilizing compounds (i.e., ethanol, strontium, or 263 
calcium ionophore) to foster the initial calcium release in the cytoplasm: protein kinase 264 
inhibitors or protein synthesis inhibitors (i.e., cycloheximide or 6-dimethylaminopurine) to 265 
inactivate the maturation promoting factor and/or the cytostatic factor and, finally, a 266 
microfilament inhibitor (i.e., cytochalasin B) to avoid the extrusion of the second polar body 267 
[90] and [91]. Indeed, avoiding the extrusion of the second polar body is necessary to maintain 268 
the diploidy in the future embryo (Fig. 1) [92]. Thus, diploid parthenotes only possess maternal 269 
genetic information and will be homozygous. In particular, diploid parthenotes will not present 270 
the two sets of maternal and paternal imprinted genes, reason why, mammalian parthenotes 271 
never develop completely unless genetically modified or by the production of chimeras with 272 
fertilized embryos [93], [94] and [95]. 273 
 Therapeutically, because these embryos are not normally viable for full development, 274 
parthenotes are also being studied as a stem cell source as it would carry very few ethical issues 275 
[88]. Moreover, parthenotes are an effective tool to evaluate genetic effects on the process of 276 
maternal genomic imprinting [94] and [96]. They also offer a means to study the contribution 277 
of maternally derived factors, as well as the absence of paternal factors to early development. 278 
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In NT experiments, oocyte activation is performed after NT to induce the resumption of meiosis 279 
in the oocyte's cytoplasm. Comparing cloned embryos and parthenotes can, therefore, be 280 
particularly helpful when it comes to study the precise cytoplasmic factors required for 281 
reprogramming within the recipient oocyte. Chromatin reorganization has been compared 282 
between fertilized embryos, clones, and parthenotes in few studies. Parthenotes seem to have 283 
less problems than their counterpart cloned embryos in adopting the proper heterochromatin 284 
conformation at very early stages, at least in mouse and rabbit embryos (Fig. 2) [59] and [97]. 285 
On the other hand, some epigenetic modifications take place more rapidly in parthenotes. 286 
Acetylation of histone H4 after formation of the pronuclei has been observed earlier in bovine 287 
and mouse parthenotes, probably due to the absence of the paternal genome [41] and [98]. 288 
Remarkably, we observed in a preliminary study that supplementation of TSA during the first 289 
embryonic cycle as in NT experiments resulted in an even more open chromatin structure in 290 
term of histone acetylation and in extended survival of mouse parthenotes post implantation 291 
(unpublished data). All these observations make parthenotes an interesting model to study 292 
reprogramming by the oocyte's cytoplasmic factors, in the absence of any sperm supply. 293 
 294 
Conclusion and Perspectives 295 
Epigenetics is the area of molecular science which has been dusted off the shelves and gained 296 
a newfound interest. In order to have a better comprehension of the complex interrelationships 297 
between all the various components of the epigenome and the way that each individual part 298 
operates, it has been essential to decipher key elements of the nuclear reprogramming in early 299 
embryos. However, understanding the connection between chromatin structure, gene 300 
expression, genome organization, creation of the nuclear architecture, and how all these cellular 301 
processes come together during embryogenesis still needs further studies. What it also needs to 302 
be remembered is that epigenetic changes can arise from external agents such as environmental 303 
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cues, dietary, stress, and chemical contaminants to mention some examples, which in turn, 304 
cause a chain effect to the chromatin modifying agents and their respective genes or gene 305 
families affecting normal development and disease through their actions on the epigenome [10]. 306 
This is particularly important from a clinical point of view. Indeed, the main goal in a fertility 307 
clinic is to raise embryos under the best culture conditions after gamete retrieving and in vitro 308 
fertilization to afterward transfer the highest quality embryo to the mother's uterus and achieve 309 
a successful pregnancy [99]. This is nowadays an effective and common process thanks to all 310 
the research and advancements in assisted reproductive technologies which have been based on 311 
the knowledge obtained from studies mainly using mouse embryos because of their easy access 312 
and manipulation. Therefore, studies in early mammalian embryos (such as mouse or rabbit) 313 
and their reprogramming could possibly help to improve embryo culture conditions to promote 314 
development of better quality embryos with higher potential for further development, thus 315 
increasing the success rates of assisted reproductive technologies [30], [35] and [51]. 316 
Elucidation of the roles of epigenetic marks in nuclear reprogramming would also benefit 317 
human health, especially the reprogramming of iPS cells. In particular, some recent publications 318 
suggest that ES cells derived from cloned embryos may be closer to ES cells derived from in 319 
vitro derived embryos than iPS cells in terms of epigenome and transcriptome [82] and [100]. 320 
We hope better understanding of epigenetic remodeling mechanisms will shed some light on 321 
cell reprogramming and further application on stem cell therapies.  322 
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Figure legends 589 
Figure 1: Strategies used to induce nuclear reprogramming include (from left to right): 590 
induction by overexpression of embryonic pluripotent transcription factors, nuclear transfer of 591 
somatic cell nuclei into enucleated recipient oocytes, fertilization through sperm penetration 592 
and parthenogenesis by artificial activation. 593 
Figure 2: Examples of H3K9me3 immuno-staining (green) with DNA counterstaining (red) on 594 
nuclei from mouse oocytes in NSN (non-surrounded nucleolus) versus  SN (surrounded 595 
nucleolus) oocytes and in 1-cell stage embryos: either fertilized (zygotes), cloned (obtained by 596 
nuclear transfer - NT) or parthenotes. Clear compaction of chromatin and accumulation of 597 
H3K9me3 can be observed in SN oocytes. After fertilization, asymmetric distribution can then 598 
be observed between the maternal and paternal pronuclei (mPN and pPN respectively) with 599 
H3K9me3 accumulation around the nucleolus precursor; whereas cloned embryos present no 600 
asymmetry with much more aggregates of H3K9me3, especially at the nuclear periphery.  Bar= 601 
10µm 602 
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